Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,415.00+0.36%ETH$2,246.32+1.22%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
SD

NASDAQ · SDGR

Schrödinger, Inc.

Healthcare · Medical - Healthcare Information Services

$27.14

Down-$2.85 (-9.50%)

Updated Oct 31, 2026, 7:04 PM

SID Score

5.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.34B
P/E ratio
-7.34
Dividend yield
0.00%
52-week range
$10.95 – $33.78
Volume
1.95M
Avg. volume
1.08M

Price performance · SDGR

SDGR price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

SDGR closed at $27.14 after 21 trading sessions, down 10.46% for the selected period.

Last close
$27.14
Period change
-10.46%
Period low
$22.60
Period high
$32.60
Daily close
View OHLC price history
SDGR OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$29.00$29.44$26.41$27.141.95M
Oct 29, 2026$30.42$31.00$29.83$29.991.36M
Oct 28, 2026$27.07$31.07$26.80$30.873.32M
Oct 27, 2026$24.87$27.28$24.50$26.721.52M
Oct 26, 2026$23.89$24.89$23.26$24.501.26M
Oct 23, 2026$22.56$23.96$22.01$23.801.16M
Oct 22, 2026$23.57$24.00$22.03$22.601.63M
Oct 21, 2026$23.55$24.26$23.24$23.901.06M
Oct 20, 2026$22.77$23.70$21.73$23.401.38M
Oct 19, 2026$22.85$23.53$22.57$23.121.43M
Oct 16, 2026$25.69$26.00$22.57$22.602.72M
Oct 15, 2026$24.50$26.14$24.01$25.482.37M
Oct 14, 2026$25.36$25.80$24.96$25.051.29M
Oct 13, 2026$25.71$26.232$25.495$25.891.3M
Oct 12, 2026$27.10$27.51$25.41$25.912.15M
Oct 9, 2026$26.61$28.1624$26.37$27.282.08M
Oct 8, 2026$26.79$27.05$25.69$26.393.08M
Oct 7, 2026$27.81$28.4299$26.8701$27.294.56M
Oct 6, 2026$32.985$33.78$28.56$28.905.26M
Oct 5, 2026$30.33$33.09$29.56$32.604.62M
Oct 2, 2026$30.74$31.14$29.28$30.313.05M

Latest SDGR news

The latest Smart Investors Daily articles mentioning SDGR.

Stock researchCompany · Overview

SDGR research

Overview

Company profile and research snapshot.

Company profile

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$19.00
Implied upside
—
Analysts
15
SDGR recent ratings
DateFirmRatingTarget
Oct 20, 2026UBSNeutral—
Oct 16, 2026KeybancOverweight—
Oct 13, 2026TD CowenBuy—
Oct 12, 2026BMO CapitalOutperform—
May 14, 2026Morgan StanleyEqual-Weight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 26, 2026

Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK, October 26, 2026--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on October 21, 2026, the company granted restricted stock units (RSUs) with respect to 5,716 shares of the company’s common stock to five newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company’s board of directors, and were made as a material inducement

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By